76 related articles for article (PubMed ID: 7137863)
1. [Study of the antiarrhythmic effects of Sotalol given orally].
Fauchier JP; Neel C; Garabedian V; Cosnay P; Brochier M
Ann Cardiol Angeiol (Paris); 1982 Jun; 31(4):329-38. PubMed ID: 7137863
[No Abstract] [Full Text] [Related]
2. Effects of sotalol in twenty patients with cardiac arrhythmias.
Latour Y; Dumont G; Brosseau A; LeLorier J
Int J Clin Pharmacol Biopharm; 1977 Jun; 15(6):275-8. PubMed ID: 881280
[TBL] [Abstract][Full Text] [Related]
3. [Brazilian multicenter study of sotalol effectiveness in ventricular arrhythmias].
Maia IG; Lorga AM; de Paola AA; Rassi A; Perez AK; Sobral D; Atie J; Gizzi JC; Darwich R
Arq Bras Cardiol; 1996 Mar; 66(3):173-8. PubMed ID: 8762699
[TBL] [Abstract][Full Text] [Related]
4. Clinical experience with sotalol in the treatment of cardiac arrhythmias.
Kirschenbaum HL; Rosenberg JM
Clin Ther; 1994; 16(3):346-64. PubMed ID: 7923303
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of acute cardiac arrhythmias using adrenergic beta blockaders. Experience with sotalol].
Martín Jadraque L; Liste Jiménez D; González Maqueda I; Del Rio Bustos A
Rev Esp Cardiol; 1975; 38(2):153-62. PubMed ID: 1135483
[No Abstract] [Full Text] [Related]
6. Use of a combination of class III and class Ic antiarrhythmic agents in patients with electrical storm.
Fuchs T; Groysman R; Meilichov I
Pharmacotherapy; 2008 Jan; 28(1):14-9. PubMed ID: 18154469
[TBL] [Abstract][Full Text] [Related]
7. Sotalol: a beta blocker with unique antiarrhythmic properties.
Singh BN; Nademanee K
Am Heart J; 1987 Jul; 114(1 Pt 1):121-39. PubMed ID: 3300230
[No Abstract] [Full Text] [Related]
8. Sotalol marketed for life-threatening arrhythmias.
Clin Pharm; 1993 Mar; 12(3):176. PubMed ID: 8491074
[No Abstract] [Full Text] [Related]
9. [Therapy of drug-resistant ventricular arrhythmias].
Lessem JN; Hamby RA
Fortschr Med; 1986 Nov; 104(41):784-6. PubMed ID: 3804148
[No Abstract] [Full Text] [Related]
10. Sotalol in patients with implanted automatic defibrillators: effects on defibrillation and comparison with amiodarone.
Dorian P; Newman D; Harris L; Downar E
Can J Cardiol; 1994 Mar; 10(2):193-200. PubMed ID: 8143220
[TBL] [Abstract][Full Text] [Related]
11. [Sotalol].
Herzig S; Beyer T
Dtsch Med Wochenschr; 1994 Oct; 119(43):1477-8. PubMed ID: 7956772
[No Abstract] [Full Text] [Related]
12. The effect of oral magnesium, alone or as an adjuvant to sotalol, after cardioversion in patients with persistent atrial fibrillation.
Frick M; Darpö B; Ostergren J; Rosenqvist M
Eur Heart J; 2000 Jul; 21(14):1177-85. PubMed ID: 10924301
[TBL] [Abstract][Full Text] [Related]
13. The role of class III antiarrhythmic agents in maintaining sinus rhythm.
Brachmann J
Europace; 2000 Jul; 1 Suppl C():C10-5. PubMed ID: 11220519
[TBL] [Abstract][Full Text] [Related]
14. Effect of concomitant antiarrhythmic therapy on survival in patients with implantable cardioverter defibrillators.
Ho AT; Pai SM; Timothy P; Pai RG
Pacing Clin Electrophysiol; 2005 Jul; 28(7):647-53. PubMed ID: 16008799
[TBL] [Abstract][Full Text] [Related]
15. [Effects of sotalol on ventricular function].
Guadalajara JF; Guerrero Sierra J; Fishleder BL; Sánchez Torres G; Friedland C
Arch Inst Cardiol Mex; 1980; 50(2):203-9. PubMed ID: 7416869
[TBL] [Abstract][Full Text] [Related]
16. Is there a need for new antiarrhythmic drugs?
Roden DM
Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():13-8. PubMed ID: 8734158
[TBL] [Abstract][Full Text] [Related]
17. Relation between ventricular function and antiarrhythmic responses to sotalol.
Singh SN; Chen YW; Cohen A; Obeid M; Tracy C; Woosley RL; Fletcher RD
Am J Cardiol; 1989 Oct; 64(14):943-5. PubMed ID: 2801566
[No Abstract] [Full Text] [Related]
18. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SPPAF), a randomized, placebo-controlled trial.
Auer J; Weber T; Berent R; Puschmann R; Hartl P; Ng CK; Schwarz C; Lehner E; Strasser U; Lassnig E; Lamm G; Eber B;
Am Heart J; 2004 Apr; 147(4):636-43. PubMed ID: 15077078
[TBL] [Abstract][Full Text] [Related]
19. [Clinical study of a new antiarrhythmic agent: verapamil hydrochloride].
Warembourg H; Bertrand ME; Ginestet A
Lille Med; 1974 Oct; 19(8 Suppl 3):890-3. PubMed ID: 4463285
[No Abstract] [Full Text] [Related]
20. Pro- and antiarrhythmic effects of d-sotalol and dl-sotalol in an isolated tissue model of ischemia and reperfusion.
Pasnani JS; Ferrier GR
J Pharmacol Exp Ther; 1994 Oct; 271(1):184-92. PubMed ID: 7965713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
